Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1281

2'-Fucosyllactose

Intended Use: Intended for use as an ingredient in cow milk- and soy-based, non-exempt infant formula for term infants and formula for young children (>12 months) at a maximum level of 2.4 g/L, and in other food categories at the maximum levels shown in Table 1 of the filing letter.
Basis: Scientific procedures
Notifier: CABIO Biotech (Wuhan) Co., Ltd.
Notifier Address: Wuhan Pharmacy Park, Jiangxia Avenue
Jiangxia Economic Development Zone, Wuhan
CHINA
GRAS Notice (releasable information): GRN 1281 (in PDF) (6.4 MB)
FDA's Letter: Pending
-
-